整形外科用デバイスの世界市場-2025～2033年

整形外科用デバイスの世界市場は、2024年に585億6,000万米ドルに達し、2033年には865億6,000万米ドルに達すると予測され、予測期間2025年のCAGRは4.1%で成長すると予測されています。

整形外科用デバイスは、骨、関節、軟部組織などの筋骨格系コンポーネントの治療、サポート、交換に使用される専門医療機器です。これらの機器は、外傷、先天性異常、変性疾患によって引き起こされるさまざまな問題をコントロールするために不可欠です。外科的治療、非外科的治療のいずれにおいても不可欠であり、筋骨格系に問題を抱える患者の治癒を早め、生活の質を向上させることができます。身体的なサポートに加え、整形外科用デバイスは回復期間を短縮し、リハビリテーションの過程を増加させることで、患者の予後を大幅に向上させます。特に、人工関節置換術や骨折固定術を受けた患者は、適切な治癒を保証し、問題を予防するために、回復期間中、これらの器具に頼ることが多くなります。

整形外科疾患の有病率の増加は、予測期間中の市場を牽引する要因です。例えば、米国国立衛生研究所によると、米国では50歳以上の1,000万人が股関節骨粗鬆症に苦しんでいます。さらに、50歳以上の3,360万人が骨量の少ない、あるいは股関節の骨減少症であり、骨粗鬆症やそれに関連する問題のリスクがあります。

市場力学：

促進要因と阻害要因

整形外科疾患の有病率の増加

整形外科疾患の有病率の増加は、世界の整形外科用デバイス市場の成長における重要な要因になると予測されます。整形外科用デバイスの世界市場は、整形外科疾患の有病率の上昇を主因として、大きく拡大する見込みです。これらの疾患は、筋骨格系に影響を及ぼす広範な問題を含み、その有病率の増加とそれに伴う世界中のヘルスケアシステムへの経済的影響により、公衆衛生の主要な懸念事項として浮上しています。整形外科疾患の増加により、整形外科用デバイスの需要は増加しています。

例えば、世界保健機関（WHO）によると、関節リウマチは世界で約1,800万人が罹患しています。関節リウマチ患者の約70％は女性で、55％が55歳以上です。関節リウマチは1,300万人が罹患しており、その重症度は様々です。整形外科疾患の有病率の増加を抑えるため、大手メーカーは様々な整形外科疾患の治療に役立つ整形外科用デバイスを発売しています。例えば、2023年2月には、曲がった骨の骨折を修復する医療機器のメーカーであるCurvaFix, Inc.が、手術を簡略化し、小骨の患者に強固で安定した固定を与えることを目的とした直径7.5mmの小径CurvaFix IM Implantの発売を発表しました。

ロボット手術、コンピューター支援手術技術、生体適合性材料の発見は、整形外科の状況を一変させました。これらの開発により、手術の正確さだけでなく、患者の転帰や回復期間も改善されています。ヘルスケアプロバイダーがこれらの新技術を採用することで、整形外科ソリューションに対するニーズの高まりに対応する準備が整うことになります。

デバイスの高コスト

デバイスの高コストなどの要因が、世界の整形外科用デバイス市場を阻害すると予想されます。世界の整形外科用デバイス市場は、特にこれらの医療技術の高コストを考えると、大きな課題に直面しています。整形外科用デバイスの開発、生産、マーケティングには多額の費用が必要であり、その結果、エンドユーザーにとっては高価格となります。この価格負担は、特にヘルスケア資金が限られている低所得地域において、患者が必要な治療を受けることを制限するかもしれません。例えば、米国国立衛生研究所によると、インプラントの費用は、基本的なものから高度なものまで、350ドルから6,370ドルです。インプラントの1症例あたりの平均費用は2,817ドル（1,250ドルから7,270ドルの範囲）となっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 整形外科疾患の罹患率の増加
  • 抑制要因
    • デバイスの高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 製品タイプ別

• 整形外科用固定器具
• 整形外科用置換器具
• 整形外科用インプラントおよび補綴物
• 整形外科用ブレース
• インプラント手術器具

第7章 用途別

• 骨折治療
• 変形性関節症
• 脊椎疾患
• スポーツ傷害
• 骨粗鬆症
• 頭蓋顎顔面障害
• その他

第8章 エンドユーザー別

• 病院
• 専門クリニック
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Stryker Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Zimmer Biomet
• Synthes Inc.
• Sonoma Orthopaedic Products Inc.
• Medtronic
• Wright Medical Group N.V
• Orthofix Medical Inc.
• Integra LifeSciences
• Arthrex Inc.
• Smith & Nephew plc.

第12章 付録

The global orthopedic devices market reached US$ 58.56 billion in 2024 and is expected to reach US$ 86.56 billion by 2033, growing at a CAGR of 4.1% during the forecast period 2025-2033.

Orthopedic devices are specialized medical equipment used to treat, support, and replace musculoskeletal system components such as bones, joints, and soft tissues. These devices are essential for controlling a wide range of problems caused by trauma, congenital abnormalities, or degenerative diseases. They are vital in both surgical and non-surgical treatments, allowing patients with musculoskeletal problems to heal more quickly and improve their quality of life. In addition to physical support, orthopedic devices can considerably enhance patient outcomes by shortening recovery durations and increasing rehabilitation processes. Especially after surgeries involving joint replacements or fracture fixations, patients frequently rely on these devices during their recovery period to guarantee appropriate healing and prevent problems.

The increasing prevalence of orthopedic disorders is the driving factor that drives the market over the forecast period. For instance, according to the National Institute of Health, In the United States, ten million people over the age of fifty suffer from hip osteoporosis. An additional 33.6 million people over the age of 50 have low bone mass or osteopenia of the hip, putting them at risk for osteoporosis and associated problems later in life.

Market Dynamics: Drivers & Restraints

Increasing prevalence of orthopedic disorders

The increasing prevalence of orthopedic disorders is expected to be a significant factor in the growth of the global orthopedic devices market. The global orthopedic devices market is poised for significant expansion, owing mostly to the rising prevalence of orthopedic diseases. These disorders, which include a wide spectrum of problems affecting the musculoskeletal system, have emerged as a major public health concern due to their increasing prevalence and the corresponding economic impact on healthcare systems around the world. Due to the increasing number of orthopedic disorders, the demand for orthopedic devices increases.

For instance, according to the World Health Organization, rheumatoid arthritis affects around 18 million people globally. Women account for around 70% of those with rheumatoid arthritis, with 55% being over the age of 55. Rheumatoid arthritis affects 13 million people, with varying degrees of severity. In order, to reduce the increasing prevalence of orthopedic diseases, major manufacturers have launched orthopedic devices that are useful in the treatment of various orthopedic disorders. For instance, in February 2023, CurvaFix, Inc., a manufacturer of medical devices that repair fractures in bent bones, announced the release of its smaller-diameter, 7.5mm CurvaFix IM Implant, which is intended to simplify surgery and give strong, stable fixation in small-bone patients.

Robotic procedures, computer-assisted surgical techniques, and the discovery of biocompatible materials have transformed the orthopedic landscape. These developments improve not only surgical precision but also patient outcomes and recuperation timelines. As healthcare providers adopt these new technologies, they will be better prepared to meet the growing need for orthopedic solutions.

High costs of devices

Factors such as high costs of devices are expected to hamper the global orthopedic devices market. The worldwide orthopedic devices market meets significant challenges, particularly given the high cost of these medical technologies. The development, production, and marketing of orthopedic devices require significant expenditure, resulting in higher prices for end users. This price burden might limit patient's access to required therapies, particularly in low-income areas where healthcare funds are limited. For instance, according to the National Institute of Health, the costs of implants range from $350 to $6,370 right from the basic device to advanced versions. The average per-case cost for an implant was $2,817 (range $1,250 to $7,270).

Segment Analysis

The global orthopedic devices market is segmented based on product type, application, end-user, and region.

Orthopedic braces segment is expected to dominate the global orthopedic devices market share

The orthopedic braces segment is anticipated to dominate the global orthopedic devices market owing to its essential function in several applications across diverse scientific fields. The orthopedic braces sector is anticipated to dominate the worldwide orthopedic devices market, owing to a number of important factors including rising demand for these devices and their critical role in patient care, technological advances, and new product launches. The increasing prevalence of orthopedic diseases, such as arthritis, osteoporosis, and sports-related injuries, has created a greater demand for appropriate support and stabilization solutions.

For instance, according to the International Osteoporosis Foundation, Osteoporosis is predicted to impact 200 million women worldwide, roughly one-tenth of women aged 60, one-fifth of women aged 70, two-fifths of women aged 80, and two-thirds of women aged 90. Furthermore, technological developments in materials and technology have significantly enhanced the functionality and comfort of orthopedic braces. Lightweight materials, customized fits, and integrated support systems have increased the appeal of these devices to patients and healthcare providers. There are recent launches in which the latest technology is being involved in the device. For instance, in August 2024, Aspen Medical Products introduced the Align Orthosis. Align Orthosis, developed in partnership with spine surgeon Han Jo Kim, MD of the Hospital for Special Surgery, is the first prefabricated TLSO designed to reduce the incidence of proximal junctional kyphosis (PJK) after surgery.

Geographical Analysis

North America is expected to hold a significant position in the global orthopedic devices market share

North America is expected to hold a significant portion of the global orthopedic devices market. North America will likely account for a significant share of the global orthopedic devices market, owing to its well-established healthcare infrastructure, high demand for novel medical devices, and an increasing patient population requiring orthopedic procedures. As osteoarthritis and osteoporosis become more frequent, the demand for effective orthopedic solutions continues to increase, boosting market expansion in this region.

For instance, according to the Bone Health and Osteoporosis Foundation, approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone. One in two women and up to one in four men will break a bone in their lifetime due to osteoporosis. For women, the incidence is greater than that of heart attack, stroke, and breast cancer combined. Moreover, according to John Hopkins Medicine, 30% of Caucasian postmenopausal women in the United States have osteoporosis, while 54% have osteopenia. The incidence of deficient bone mass rises with age.

The presence of major players in this region, recent product launches, and FDA approvals make North America hold the highest market share. For instance, in October 2024, Smith+Nephew announced that it had launched its Legion-hinged knee (HK) system with Oxinium implant technology in the United States. This implant technology outperforms both metal durability and ceramic wear resistance, as well as corrosion resistance.

Asia Pacific is growing at the fastest pace in the global orthopedic devices market

The Asia Pacific region is emerging as the fastest-growing market for orthopedic devices, owing to a combination of demographic trends, increased healthcare investment, recent launches, and an increasing prevalence of orthopedic diseases. This growth is largely attributed to the rapid increase in the aging population across countries like China and India, where the demand for orthopedic interventions is surging due to age-related conditions such as osteoarthritis and osteoporosis.

For instance, according to the World Health Organization (WHO), 30% of postmenopausal women suffer from osteoporosis. It has been reported that around six crore people in India have osteoporosis and 80% of them are women. The peak incidence of osteoporosis in India occurs 10 - 20 years earlier than in Western countries.

Competitive Landscape

The major global players in the global orthopedic devices market include Stryker Corporation, Zimmer Biomet, Synthes Inc., Sonoma Orthopaedic Products Inc., Medtronic, Wright Medical Group N.V, Orthofix Medical Inc., Integra LifeSciences, Arthrex Inc., Smith & Nephew plc. among others.

Emerging Players

Stoko, Canary Medical, and Loci Orthopedics among others

Key Developments

• In March 2024, Stryker, a global leader in medical technologies, announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets. The newest Gamma system will provide surgeons with the next generation of Stryker's intramedullary nailing system. The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
• In October 2023, DePuy Synthes, the orthopedic device business of Johnson & Johnson, has won FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system. TriLeap offers a wide range of plate options tailored for various procedures and screw diameters, according to DePuy Synthes. Its instruments can be used during the reduction, internal fixation, and fusion of bones and bone fragments.
• In August 2023, Enovis Corp. acquired Novastep SAS and its foot and ankle minimally invasive surgical (MIS) platform from Amplitude Surgical SAS for €68 million.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global orthopedic devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Orthopedic Disorders
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Orthopedic Fixation Devices*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Orthopedic Replacement Devices
• 6.4. Orthopedic Implants and Prosthetics
• 6.5. Orthopedic Braces
• 6.6. Implant Surgical Devices

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Fracture Treatment*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Osteoarthritis
• 7.4. Spinal Disorders
• 7.5. Sports Injuries
• 7.6. Osteoporosis
• 7.7. Cranio-maxillofacial Disorders
• 7.8. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Specialty Clinics
• 8.4. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. The U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Stryker Corporation*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Zimmer Biomet
• 11.3. Synthes Inc.
• 11.4. Sonoma Orthopaedic Products Inc.
• 11.5. Medtronic
• 11.6. Wright Medical Group N.V
• 11.7. Orthofix Medical Inc.
• 11.8. Integra LifeSciences
• 11.9. Arthrex Inc.
• 11.10. Smith & Nephew plc.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us